Literature DB >> 17585805

Complex formation of bovine serum albumin with a poly(ethylene glycol) lipid conjugate.

Valeria Castelletto1, Marta Krysmann, Antonios Kelarakis, Paula Jauregi.   

Abstract

In this work, we report the formation of complexes by self-assembly of bovine serum albumin (BSA) with a poly(ethylene glycol) lipid conjugate (PEG2000-PE) in phosphate saline buffer solution (pH 7.4). Three different sets of samples have been studied. The BSA concentration remained fixed (1, 0.01, or 0.001 wt % BSA) within each set of samples, while the PEG2000-PE concentration was varied. Dynamic light scattering (DLS), rheology, and small-angle X-ray scattering (SAXS) were used to study samples with 1 wt % BSA. DLS showed that BSA/PEG2000-PE aggregates have a size intermediate between a BSA monomer and a PEG2000-PE micelle. Rheology suggested that BSA/PEG2000-PE complexes might be surrounded by a relatively compact PEG-lipid shell, while SAXS results showed that depletion forces do not take an important role in the stabilization of the complexes. Samples containing 0.01 wt % BSA were studied by circular dichroism (CD) and ultraviolet fluorescence spectroscopy (UV). UV results showed that at low concentrations of PEG-lipid, PEG2000-PE binds to tryptophan (Trp) groups in BSA, while at high concentrations of PEG-lipid the Trp groups are exposed to water. CD results showed that changes in Trp environment take place with a minimal variation of the BSA secondary structure elements. Finally, samples containing 0.001 wt % BSA were studied by zeta-potential experiments. Results showed that steric interactions might play an important role in the stabilization of the BSA/PEG2000-PE complexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17585805     DOI: 10.1021/bm070116o

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  7 in total

1.  Long-Circulating Amphiphilic Doxorubicin for Tumor Mitochondria-Specific Targeting.

Authors:  Jingchao Xi; Meng Li; Benxin Jing; Myunggi An; Chunsong Yu; Cameron B Pinnock; Yingxi Zhu; Mai T Lam; Haipeng Liu
Journal:  ACS Appl Mater Interfaces       Date:  2018-12-06       Impact factor: 9.229

2.  Controlling lipid micelle stability using oligonucleotide headgroups.

Authors:  Samantha E Wilner; Samuel E Sparks; David Cowburn; Mark E Girvin; Matthew Levy
Journal:  J Am Chem Soc       Date:  2015-02-03       Impact factor: 15.419

3.  Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates.

Authors:  He Dong; Nikhil Dube; Jessica Y Shu; Jai W Seo; Lisa M Mahakian; Katherine W Ferrara; Ting Xu
Journal:  ACS Nano       Date:  2012-05-04       Impact factor: 15.881

4.  In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.

Authors:  Leonie Baginski; Oliviero L Gobbo; Frederic Tewes; Johanna J Salomon; Anne Marie Healy; Udo Bakowsky; Carsten Ehrhardt
Journal:  Pharm Res       Date:  2012-02-10       Impact factor: 4.200

5.  Two-Photon Macromolecular Probe Based on a Quadrupolar Anthracenyl Scaffold for Sensitive Recognition of Serum Proteins under Simulated Physiological Conditions.

Authors:  Marco Deiana; Bastien Mettra; Leszek M Mazur; Chantal Andraud; Marek Samoc; Cyrille Monnereau; Katarzyna Matczyszyn
Journal:  ACS Omega       Date:  2017-09-12

6.  Affibody Modified G-quadruplex DNA Micelles Incorporating Polymeric 5-Fluorodeoxyuridine for Targeted Delivery of Curcumin to Enhance Synergetic Therapy of HER2 Positive Gastric Cancer.

Authors:  Chao Zhang; Shuangqing Fu; Fanghua Zhang; Mengnan Han; Xuming Wang; Jie Du; Honglei Zhang; Wei Li
Journal:  Nanomaterials (Basel)       Date:  2022-02-19       Impact factor: 5.076

7.  Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery.

Authors:  Ashita Nair; Jiyoon Bu; Jason Bugno; Piper A Rawding; Luke J Kubiatowicz; Woo-Jin Jeong; Seungpyo Hong
Journal:  Biomacromolecules       Date:  2021-07-28       Impact factor: 6.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.